v3.26.1
Revenue (Tables)
6 Months Ended
Jun. 30, 2026
Revenue from Contract with Customer [Abstract]  
Schedule of revenue disaggregated by Group, end customer geographical location and timing of recognition

The following table presents the Company’s revenues by end customer geography for the periods reported (in millions):

 

 

 

Three Months Ended
June 30,

 

 

Six Months Ended
June 30,

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

United States

 

$

248.2

 

 

$

222.9

 

 

$

470.1

 

 

$

440.3

 

Germany

 

 

64.4

 

 

59.1

 

 

127.1

 

 

120.2

 

Europe excluding Germany

 

 

244.3

 

 

213.4

 

 

503.2

 

 

437.5

 

China

 

 

104.9

 

 

114.7

 

 

178.9

 

 

215.9

 

Asia Pacific excluding China

 

 

112.4

 

 

127.4

 

 

 

247.1

 

 

258.8

 

Other

 

 

64.3

 

 

59.9

 

 

135.5

 

 

126.1

 

Total revenue

 

$

838.5

 

 

$

797.4

 

 

$

1,661.9

 

 

$

1,598.8

 

 

The following table presents revenue for the Company recognized at a point in time versus over time for the periods reported (in millions):

 

 

Three Months Ended
June 30,

 

 

Six Months Ended
June 30,

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Revenue recognized at a point in time

 

$

698.4

 

 

$

675.1

 

 

$

1,386.7

 

 

$

1,353.8

 

Revenue recognized over time

 

 

140.1

 

 

 

122.3

 

 

 

275.2

 

 

 

245.0

 

Total revenue

 

$

838.5

 

 

$

797.4

 

 

$

1,661.9

 

 

$

1,598.8

 

Schedule of contract balances associated with revenue

As of June 30, 2026, and December 31, 2025, the following balances were associated with revenue (in millions):

 

 

 

June 30,
2026

 

 

December 31,
2025

 

Contract assets

 

$

117.5

 

 

$

113.0

 

Contract liabilities (a)

 

$

555.7

 

 

$

550.4

 

Remaining performance obligations (b)

 

$

2,775.6

 

 

$

2,569.4

 

(a)
Approximately $294.0 million of the contract liability balance on December 31, 2025, was recognized as revenue during the six months ended June 30, 2026.
(b)
Bruker’s mix of remaining performance obligations consist of firm orders under non-cancelable purchase orders received from customers and the timing of revenue recognition can vary significantly due to a variety of factors. Bruker manufactures innovative scientific instruments and diagnostic solutions which can result in varying production and installation timing due to components, customization, manufacturing, assembly, testing processes, and customer site availability or readiness. Bruker’s expected completion of performance obligations can vary from year to year based on these and other factors. As a result, performance obligations on any particular date may be indicative of Bruker’s short-term revenue performance but is not necessarily a reliable indicator of long-term revenue performance. The Company will recognize revenues for these performance obligations as they are satisfied, the majority of which is expected to occur within the next twelve months.